CC

Commodore Capital Portfolio holdings

AUM $1.42B
This Quarter Return
+18.68%
1 Year Return
+73.3%
3 Year Return
+1,330.82%
5 Year Return
–
10 Year Return
–
AUM
$432M
AUM Growth
+$432M
Cap. Flow
+$50.7M
Cap. Flow %
11.73%
Top 10 Hldgs %
72.69%
Holding
32
New
3
Increased
10
Reduced
2
Closed
7

Top Buys

1
BLU
BELLUS Health Inc.
BLU
$25.2M
2
MRUS icon
Merus
MRUS
$24.8M
3
XENE icon
Xenon Pharmaceuticals
XENE
$16M
4
TCDA
Tricida, Inc. Common Stock
TCDA
$11.9M
5
PTGX icon
Protagonist Therapeutics
PTGX
$10.5M

Top Sells

1
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
$26.1M
2
KURA icon
Kura Oncology
KURA
$18.7M
3
CLDX icon
Celldex Therapeutics
CLDX
$13.4M
4
IOVA icon
Iovance Biotherapeutics
IOVA
$8.95M
5
RVMD icon
Revolution Medicines
RVMD
$6.22M

Sector Composition

1 Healthcare 99.43%
2 Financials 0.57%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
ISEE
1
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$53.8M 12.46%
3,217,163
+467,026
+17% +$7.81M
MRUS icon
2
Merus
MRUS
$4.98B
$47.7M 11.04%
1,498,890
+780,754
+109% +$24.8M
ACRS icon
3
Aclaris Therapeutics
ACRS
$209M
$38.9M 9%
2,672,346
+482,055
+22% +$7.01M
XENE icon
4
Xenon Pharmaceuticals
XENE
$2.98B
$34.1M 7.89%
1,090,126
+510,694
+88% +$16M
CYTK icon
5
Cytokinetics
CYTK
$4.23B
$32.1M 7.44%
704,537
-92,041
-12% -$4.2M
PTGX icon
6
Protagonist Therapeutics
PTGX
$3.67B
$27.6M 6.38%
805,573
+307,494
+62% +$10.5M
BLU
7
DELISTED
BELLUS Health Inc.
BLU
$25.2M 5.83%
+3,124,613
New +$25.2M
COGT icon
8
Cogent Biosciences
COGT
$1.69B
$19.6M 4.53%
2,281,315
+368,804
+19% +$3.16M
CBAY
9
DELISTED
Cymabay Therapeutics
CBAY
$18.3M 4.24%
5,419,896
+1,250,000
+30% +$4.22M
VRDN icon
10
Viridian Therapeutics
VRDN
$1.5B
$16.8M 3.88%
847,683
+180,009
+27% +$3.56M
STSA
11
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
$16.7M 3.87%
3,711,286
+592,525
+19% +$2.67M
VTGN icon
12
VistaGen Therapeutics
VTGN
$102M
$16.5M 3.82%
8,464,999
+3,341,490
+65% +$6.52M
CCCC icon
13
C4 Therapeutics
CCCC
$185M
$15.5M 3.59%
481,094
– –
CELC icon
14
Celcuity
CELC
$2.17B
$12.1M 2.81%
920,464
– –
TCDA
15
DELISTED
Tricida, Inc. Common Stock
TCDA
$11.9M 2.76%
+1,247,043
New +$11.9M
TNYA icon
16
Tenaya Therapeutics
TNYA
$184M
$9.74M 2.26%
513,930
– –
ALLK
17
DELISTED
Allakos
ALLK
$7.99M 1.85%
+815,667
New +$7.99M
KALV icon
18
KalVista Pharmaceuticals
KALV
$678M
$4.14M 0.96%
312,553
– –
KRON
19
DELISTED
Kronos Bio
KRON
$4.06M 0.94%
298,839
– –
DYN icon
20
Dyne Therapeutics
DYN
$1.92B
$3.63M 0.84%
305,125
– –
IVA
21
Inventiva
IVA
$861M
$3.59M 0.83%
262,658
– –
GNCA
22
DELISTED
Genocea Biosciences, Inc.
GNCA
$3.57M 0.83%
3,079,756
– –
MREO
23
Mereo BioPharma
MREO
$272M
$3.13M 0.72%
1,954,970
-17,988
-0.9% -$28.8K
PMVP icon
24
PMV Pharmaceuticals
PMVP
$74.2M
$2.89M 0.67%
125,000
– –
BLSA
25
DELISTED
BCLS Acquisition Corp. Class A Ordinary Shares
BLSA
$2.45M 0.57%
250,000
– –
1
2